新型冠状病毒肺炎疫情防控期间疟疾患者血样检测的思考和建议

doi:10.12140/j.issn.1000-7423.2020.04.011

摘要/Abstract

摘要：

目前全球新型冠状病毒肺炎（COVID-19）疫情不断蔓延,自境外疟疾流行区入境人员存在疟原虫及新型冠状病毒（SARS-CoV-2）双重感染风险,为及时、准确、安全地开展疟疾检测,保障输入性疟疾的早发现、早诊断和早治疗,笔者提出在COVID-19疫情防控期间,疟疾患者血样检测工作中需提高生物安全防护级别、优先采用快速诊断检测（RDT）和核酸检测方法、至少两种检测方法结果一致作为虫种确认依据、实施血片特殊制备的方法等建议,供各临床和疾控实验室参考。

关键词: 新型冠状病毒肺炎, 疟疾, 显微镜检查, 核酸检测, 快速诊断检测

Abstract:

With the ongoing global spread of coronavirus disease 2019 (COVID-19) epidemic, there is a risk of co-occurrence of malaria and COVID-19 in people returning from malaria-endemic areas abroad. In order to conduct timely, accurate and safe detection of malaria cases, ensuring early finding, diagnosis and treatment of imported malaria, we propose that facing the current pandemic situation, higher level of biosafety protective practice is needed for handling malaria blood samples with potential risk, use of rapid diagnostic test and nuclear acid detection method is the first choice, confirmation of Plasmodium species should be made based on consistency between at least two detection methods, and blood smears should be prepared with special procedures when necessary.

Key words: COVID-19, Malaria, Microscopic examination, Nucleic acid amplification tests, Rapid diagnostic test

中图分类号:

R531.3

李美, 夏志贵, 尹建海, 燕贺. 新型冠状病毒肺炎疫情防控期间疟疾患者血样检测的思考和建议[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(4): 464-468.

LI Mei, XIA Zhi-gui, YIN Jian-hai, YAN He. Consideration and recommendations for malaria blood testing during the COVID-19 pandemic[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2020, 38(4): 464-468.

参考文献 36

[1]	Zhang L, Feng J, Zhou SS, et al. Epidemiological characteristics of malaria and the progress towards its elimination in China in 2018[J]. Chin J Parasitol Parasit Dis, 2019,37(3):241-247. (in Chinese)
[1]	( 张丽, 丰俊, 周水森, 等. 2018年全国疟疾疫情特征及消除疟疾工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2019,37(3):241-247.)
[2]	Zhang L, Feng J, Zhang SS, et al. The progress of national malaria elimination and epidemiological characteristics of malaria in China in 2017[J]. Chin J Parasitol Parasit Dis, 2018,36(3):201-209. (in Chinese)
[2]	( 张丽, 丰俊, 张少森, 等. 2017年全国消除疟疾进展及疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2018,36(3):201-209.)
[3]	Zhang L, Feng J, Zhou SS, et al. Epidemiological characteristics of malaria and the progress towards its elimination in China in 2019[J]. Chin J Parasitol Parasit Dis, 2020,38(2):133-138. (in Chinese)
[3]	( 张丽, 丰俊, 夏志贵, 等. 2019年全国疟疾疫情特征及消除疟疾工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2020,38(2):133-138.)
[4]	World Health Organization. WHO coronavirus disease (COVID-19) dashboard[EB/OL]. (2020-07-17)[2020-07-17]. https://covid19.who.int/.
[5]	National Health Commission of the People’s Republic of China. The technical guidelines for novel coronavirus pneumonia diagnosis and treatment (Version 7)[Z]. Beijing: General Office of the National Health Commission of the People’s Republic of China, 2020. (in Chinese)
[5]	( 中华人民共和国国家卫生健康委办公厅. 新型冠状病毒肺炎诊疗方案(试行第七版)[Z]. 北京: 中华人民共和国国家卫生健康委办公厅, 2020.)
[6]	Tang LH, Gao Q, Yu XB, et al. WS 259-2015 Diagnosis of malaria[S]. Beijing: National Health and Family Planning Commission of the People’s Republic of China, 2015. (in Chinese)
[6]	( 汤林华, 高琪, 余新炳, 等. WS 259-2015 疟疾的诊断[S]. 北京: 中华人民共和国卫生和计划生育委员会, 2015.)
[7]	Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety[J]. Transfus Med Rev, 2020,34(2):75-80.
[8]	Grant PR, Garson JA, Tedder RS, et al. Detection of SARS coronavirus in plasma by real-time RT-PCR[J]. N Engl J Med, 2003,349(25):2468-2469.
[9]	Ng EK, Hui DS, Chan KC, et al. Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome[J]. Clin Chem, 2003,49(12):1976-1980.
[10]	Ng EK, Ng PC, Hon KL, et al. Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severeacute respiratory syndrome[J]. Clin Chem, 2003,49(12):2085-2088.
[11]	Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan[J]. Lancet, 2020,395(10223):497-506.
[12]	Disease Prevention and Control Bureau of National Health Commission of the People’s Republic of China. The technical guidelines for control novel coronavirus pneumonia (Version 2) Annex 4: guidelines for laboratory testing of new coronavirus pneumonia samples (Version 2)[Z]. Beijing: Disease Prevention and Control Bureau of National Health Commission of the People’s Republic of China, 2002. (in Chinese)
[12]	( 中华人民共和国国家卫生健康委疾病预防控制局. 新型冠状病毒感染的肺炎防控方案(第二版) 附件4: 新型冠状病毒感染的肺炎实验室检测技术指南(第二版)[Z]. 北京: 中华人民共和国国家卫生健康委疾病控制局, 2020.
[13]	Doremalen NV, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as compared with SARS-CoV-1[J]. N Engl J Med, 2020,382(16):1564-1567.
[14]	Mullis L, Saif LJ, Zhang YB, et al. Stability of bovine coronavirus on lettuce surfaces under household refrigeration conditions[J]. Food Microbiol, 2012,30(1):180-186.
[15]	Liu Y, Ning Z, Chen Y, et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals[J]. Nature, 2020,582(7813):557-560.
[16]	Kampf G, Todt D, Pfaender S, et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents[J]. J Hospit Infect, 2020,104(3):246-251.
[17]	Rabenau HF, Cinatl J, Morgenstern B, et al. Stability and inactivation of SARS coronavirus[J]. Med Microbiol Immunol, 2005,194(1/2):1-6.
[18]	Zou Y, Zheng YS, Cao J. Suggestions for standardizing the process of malaria diagnosis and treatment during the epidemic control of coronavirus disease (COVID-19)[J]. Chin J Parasitol Parasit Dis, 2020,38(1):1-4. (in Chinese)
[18]	( 邹洋, 郑以山, 曹俊. 新型冠状病毒肺炎防控期间规范疟疾诊疗流程的建议[J]. 中国寄生虫学与寄生虫病杂志, 2020,38(1):1-4.)
[19]	General Office of the National Health Commission of the People’s Republic of China. Biological safety guidelines for laboratory testing novel coronavirus (Version 2)[Z]. Beijing: General Office of the National Health Commission of the People’s Republic of China, 2020. (in Chinese)
[19]	( 中华人民共和国国家卫生健康委办公厅. 新型冠状病毒实验室生物安全指南(第二版)[Z]. 北京: 中华人民共和国国家卫生健康委办公厅, 2020.)
[20]	Lei L, Liu XS, Mao LL, et al. Evaluation of three testing methods on the diagnosis of malaria[J]. Chin J Vector Biol Control, 2015,26(2):206-208. (in Chinese)
[20]	( 雷露, 刘学升, 毛玲玲, 等. 3种实验室检测方法在疟疾诊断中的应用比较[J]. 中国媒介生物学及控制杂志, 2015,26(2):2016-210.)
[21]	Li SH, Gao LJ, Zhang YL, et al. Comprehensive analysis of three detection methods on the laboratory diagnosis of malaria[J]. Henan J Preve Med, 2018,29(4):252-254, 266. (in Chinese)
[21]	( 李素华, 高丽君, 张雅兰, 等. 3种检测方法在疟疾实验室诊断中的比较分析[J]. 河南预防医学杂志, 2018,29(4):252-254, 266.)
[22]	Wang ZY, Jiang L, Zhang YG, et al. Comparative analysis of malaria detection ability of laboratories in Shanghai City from 2012 to 2015[J]. Chin J Schisto Control, 2017,29(3):305-309, 328. (in Chinese)
[22]	( 王真瑜, 江莉, 张耀光, 等. 2012-2015年上海市实验室疟疾检测能力比较分析[J]. 中国血吸虫病防治杂志, 2017,29(3):305-309, 328.)
[23]	World Health Organization. Tailoring malaria interventions in the COVID-19 response[EB/OL]. ( 2020-04-03) [2020-04-26]. https://www.who.int/malaria/publications/atoz/tailoring-malaria-interventions-in-the-covid-19-response/en/.
[24]	China Center for Disease Control and Prevention. Technical program for malaria elimination (Version 2011)[M]. Beijing: Chinese Center for Disease Control and Prevention, 2011. (in Chinese)
[24]	( 中国疾病预防控制中心. 消除疟疾技术方案(2011年版)[M]. 北京: 中国疾病预防控制中心, 2011.)
[25]	Yin JH, Yan H, Huang F, et al. Establishing a China malaria diagnosis reference laboratory network for malaria elimination[J]. Malar J, 2015,14:40.
[26]	Li M, Wang ZY, Zhang T, et al. Exploration of using one-step reverse transcription PCR in detection of four species of human malaria parasite[J]. Chin J Parasitol Parasit Dis, 2016,34(6):500-505. (in Chinese)
[26]	( 李美, 王真瑜, 张淘, 等. 一步反转录PCR技术在检测4种人疟原虫中的初步应用[J]. 中国寄生虫学与寄生虫病杂志, 2016,34(6):500-505.)
[27]	Li M, Xia ZG, Tang LH. Establishment and application of multiplex PCR system for detecting four human Plasmodium species[J]. Chin J Parasitol Parasit Dis, 2015,33(2):91-95. (in Chinese)
[27]	( 李美, 夏志贵, 汤林华. 检测4种人体疟原虫多重PCR体系的建立和应用[J]. 中国寄生虫学与寄生虫病杂志, 2015,33(2):91-95.)
[28]	Jiang L, Wang ZY, Zhang YG, et al. Analysis on the application of three methods for malaria diagnosis[J]. Chin J Parasitol Parasit Dis, 2015,33(2):91-95. (in Chinese)
[28]	( 江莉, 王真瑜, 张耀光, 等. 3种疟疾检测方法的应用分析[J]. 中国寄生虫学与寄生虫病杂志, 2017,35(1):53-58.)
[29]	Ren LZ, Zhang Y. Principle and technology of molecular biology experiment[M]. Beijing: Science Press, 2015. ( in Chinese)
[29]	( 任林柱, 张英. 分子生物学实验原理与技术[M]. 北京: 科学出版社, 2015.)
[30]	Li M, Li Jun, Xia ZG, et al. A combined strategy for screening a clustered mobile population returning from highly endemic areas for Plasmodium falciparum[J]. J Infect Dev Ctries, 2017,11(4):287-293.
[31]	Li M, Xia ZG, Zhou SS. Analysis of inconsistence of Plasmodium detection in some malaria cases[J]. Chin J Parasitol Parasit Dis, 2019,37(4):1-8. (in Chinese)
[31]	( 李美, 夏志贵, 周水森. 疟疾病例复核确认过程中检测结果不一致常见问题分析[J]. 中国寄生虫学与寄生虫病杂志, 2019,37(4):1-8.)
[32]	Dalrymple U, Arambepola R, Gething PW, et al. How long do rapid diagnostic tests remain positive after anti-malarial treatment[J]. Malar J, 2018,17:228.
[33]	Baker J, McCarthy J, Gatton M, et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests[J]. J Infect Dis, 2005,192(5):870-877.
[34]	GMP/HTM/WHO. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2/3 gene deletions[Z/OL]. Geneva: WHO, 2017[2020-04-22]. https://www.who.int/malaria/publications/atoz/information-note-hrp2-based-rdt/en/.
[35]	Darnell ME, Taylor DR. Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products[J]. Transfusion, 2006,46(10):1770-1777.
[36]	America Center for Disease Control. Guidance for malaria diagnosis in patients suspected of Ebola infection in the United States[EB/OL]. (2015-01-15) [2020-04-22]. https://www. cdc.gov/malaria/new_info/2014/malaria_ebola.htm.